MAY 02, 2017 7:44 PM PDT

Some blood types associated with higher risk of heart disease

WRITTEN BY: Kara Marker

An intriguing link between people with non-O blood groups and a higher risk of adverse cardiac events is the subject of a new study from the European Society of Cardiology. Non-O blood groups, I.E. A, B, or AB blood groups have been associated with risk of heart problems in the past, but the newest study provides clearer evidence.

Source: Biology Questions and Answers

Past research suggesting this phenomenon came from case-control studies with not a lot of evidence, but the the present study included a meta-analysis of multiple prospective studies comparing O and non-O blood groups looking for any difference in risk for cardiovascular events: myocardial infarction AKA heart attack, coronary artery disease, ischaemic heart disease, heart failure and cardiovascular mortality.

Of nearly one-and-a-half million study subjects, an analysis of coronary and combined cardiovascular events included around 7-800,000 with a non-O blood group and 500,000 with an O blood group. Odds ratios for both analyses showed carriers of a non-O blood group to be at a higher risk of heart disease.

"We demonstrate that having a non-O blood group is associated with a 9% increased risk of coronary events and a 9% increased risk of cardiovascular events, especially myocardial infarction," explained lead author Tessa Kole.

Nine percent may not seem like a lot, studies like Kole’s at the very least shine a light on this connection for future study. In the mean time, researchers have a few guesses as to what factors could be influencing the increased risk of cardiac events for non-O blood groups.

  • Greater concentrations of von Willebrand factor, a blood clotting protein associated with thrombotic events

  • Higher cholesterol, which is common in non-O blood group carriers, particularly in the A blood group
  • Galectin-3, a biomarker linked to inflammation and poor health outcomes for heart failure patients and which is also especially high in non-O blood group

More research is necessary to understand the connection completely, but for now, Kole recommends that “blood group should be considered in risk assessment for cardiovascular prevention, together with cholesterol, age, sex and systolic blood pressure. We need further studies to validate if the excess cardiovascular risk in non-O blood group carriers may be amenable to treatment."

Source: Mayo Medical Laboratories, National Health Service, European Heart Society

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JAN 03, 2021
Cannabis Sciences
Cannabis Users Don't Understand Health Risks of Smoking, Study Finds
JAN 03, 2021
Cannabis Users Don't Understand Health Risks of Smoking, Study Finds
A recent study has found that cannabis users often classify themselves as 'non-smokers' even though they smoke c ...
JAN 09, 2021
Drug Discovery & Development
Anticoagulant Drugs Prevent Cancer Spreading to Brain
JAN 09, 2021
Anticoagulant Drugs Prevent Cancer Spreading to Brain
Researchers from the Heidelberg University in Germany have found that anticoagulant drugs that inhibit thrombin (an enzy ...
JAN 10, 2021
Cell & Molecular Biology
A New Way to Defend Against Mosquito-Borne Viruses
JAN 10, 2021
A New Way to Defend Against Mosquito-Borne Viruses
Mosquitoes are killers; they are thought to be responsible for the deaths of millions of people every year because of th ...
JAN 20, 2021
Microbiology
Cannabis Compound Could Lead to New Class of Antibiotics
JAN 20, 2021
Cannabis Compound Could Lead to New Class of Antibiotics
For the first time, a synthetic version of a non-psychoactive molecule found in marijuana has been shown to kill pathoge ...
JAN 21, 2021
Health & Medicine
Injectable Cannabis Overdose Drug Being Developed
JAN 21, 2021
Injectable Cannabis Overdose Drug Being Developed
It’s estimated that the number of visits to emergency rooms because of cannabis overdose tripled between 2011 and ...
JAN 24, 2021
Microbiology
Cholesterol Enables SARS-CoV-2 to Invade & Create 'Mega-Cells'
JAN 24, 2021
Cholesterol Enables SARS-CoV-2 to Invade & Create 'Mega-Cells'
To cause the COVID-19 illness, the SARS-CoV-2 virus first has to get into cells. To do so, it uses something called a sp ...
Loading Comments...